ipilimumab,nivolumab
bms
['neonipiga', 'spotlight', 'niche-2', 'rectal']
 imo for the msi-high, the management is changing. perfect time to put the niche-2 study at #esmo22 in the spotlight . with niche-2 data from neoadjuvant #rectalcancer neonipiga you ll find me in the #watchandwait boat. 
Oncologist | Researcher | ColorectalCancer #CRCSM???????@MayoClinic @PittTweet Alum; ??#ctDNA #LiquidBiopsies??#PrecisionOncology ViewsMy Own. COI @ASCO #ASCO22